Perioperative management of antidepressants and herbal medications in elective plastic surgery

Plastic and Reconstructive Surgery

Volumn 123, Issue 1, 2009, Pages 377-385

  Chin, Simon H ^a,b   Cristofaro, Joseph ^a,b   Aston, Sherrell J ^a,b  

^a EAR AND THROAT HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMFEBUTAMONE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; AVITRIPTAN; CLOZAPINE; DESFLURANE; ENFLURANE; FLUOXETINE; HERBACEOUS AGENT; KAVA; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PANCURONIUM; PENTAZOCINE; PETHIDINE; PROPRANOLOL DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; SUXAMETHONIUM; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALERIAN; VENLAFAXINE;

AGITATION; ANGELICA SINENSIS; ARTICLE; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CASE STUDY; CENTRAL NERVOUS SYSTEM DISEASE; CONVULSION; CORONARY ARTERY CONSTRICTION; DEPRESSION; DRUG EFFECT; ECHINACEA; ELECTIVE SURGERY; ELECTROLYTE DISTURBANCE; EPHEDRA; GARLIC; GASTROINTESTINAL SYMPTOM; GINGER; GINKGO BILOBA; GINSENG; GLYCYRRHIZA; GONORRHEA; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYDRASTIS; HYPERICUM PERFORATUM; HYPERTENSION; HYPERTENSIVE CRISIS; HYPERTHERMIA; HYPOTENSION; INSOMNIA; KIDNEY FAILURE; LETHARGY; LEUKOPENIA; LIVER TOXICITY; LUNG ARTERY PRESSURE; MAFESIAN; MEDICINAL PLANT; MEDLINE; MIGRAINE; MYOCARDITIS; NEPHROTOXICITY; NONHUMAN; PERIOPERATIVE PERIOD; PLASTIC SURGERY; POLYDIPSIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RIGIDITY; RISK FACTOR; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SILYBUM MARIANUM; SKIN DISEASE; SUDDEN DEATH; SURGEON; TACHYCARDIA; TANACETUM PARTHENIUM; TORSADE DES POINTES; WITHDRAWAL SYNDROME; HERBAL MEDICINE; METHODOLOGY; PHYTOTHERAPY; POSTOPERATIVE CARE; PREOPERATIVE CARE; REVIEW;

ANTIDEPRESSIVE AGENTS; HERBAL MEDICINE; HUMANS; PHYTOTHERAPY; POSTOPERATIVE CARE; PREOPERATIVE CARE; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL PROCEDURES, ELECTIVE;

EID: 60549101319     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181934892     Document Type: Article

References (76)

1. Freedman B. Cosmetic surgery and the use of antidepressant medication. Presented at the American Society for Plastic Surgeons Conference, San Francisco, Calif., October 6, 2006.
2. Cherry DK, Woodwell DA, Rechtsteiner EA. National ambulatory medical care survey: 2005 summary. Adv Data 2007; 387:1-39.
3. Kaye AD, Kucera I, Sabar R. Perioperative anesthesia clinical considerations of alternative medicines. Anesthesiol Clin North Am. 2004;22:125-139.
4. Sprague DH, Wolf S. Enflurane seizures in patients taking amitriptyline. Anesth Analg. 1982;61:67-68.
5. Sprung J, Schoenwald PK, Levy P, Krajewski LP. Treating intraoperative hypotension in a patient on long-term tricyclic antidepressants: A case of aborted aortic surgery. Anesthesiology 1997;86:990-992.
6. Heard K, Cain BS, Dart RC, Cairns CB. Tricyclic antidepressants directly depress human myocardial mechanical function independent of effects on the conduction system. Acad Emerg Med. 2001;8:1122-1127.
7. Ragheb M. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions. J Clin Psychopharmacol. 1990;10:350-354.
8. Hill GE, Wong KC, Hodges MR. Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 1976;44:439-442.
9. Huyse FJ, Touw DJ, van Schijndel RS, de Lange JJ, Slaets JP. Psychotropic drugs and the perioperative period: A proposal for a guideline in elective surgery. Psychosomatics 2006;47:8-22.
10. Boakes AJ, Laurence DR, Teoh PC, Barar FS, Benedikter LT, Prichard BN. Interactions between sympathomimetic amines and antidepressant agents in man. BMJ. 1973;1:311-315.
11. Livingston MG, Livingston HM. Monoamine oxidase inhibitors: An update on drug interactions. Drug Saf. 1996;14: 219-227.
12. Kam PC, Chang GW. Selective serotonin reuptake inhibitors: Pharmacology and clinical implications in anaesthesia and critical care medicine. Anaesthesia 1997;52:982-928.
13. Stack CG, Rogers P, Linter SP. Monoamine oxidase inhibitors and anaesthesia: A review. Br J Anaesth. 1988;60:222-227.
14. Mills KC. Serotonin syndrome: A clinical update. Crit Care Clin. 1997;13:763-783.
15. Dawson J, Karalliedde L. Drug interactions and the clinical anaesthetist. Eur J Anaesthesiol. 1998;15:172-189.
16. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996;16:356-362.
17. Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol. 1996;42:757-763.
18. Cook DR, Brandom BW. Enflurane, halothane, and isoflu-rane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation. Anesth Analg. 1982;61:671-675.
19. Watkins CA, Wartell SA, Rannels DE. Effect of halothane on metabolism of 5-hydroxytryptamine by rat lungs perfused in situ. Biochem J. 1983;210:157-166.
20. Hede AR, Berglund BG, Post C. Trichloroethylene and halothane inhibit uptake and metabolism of 5-hydroxytryptamine in rat lung slices. Pharmacol Toxicol. 1987;61:191-194.
21. Feighner JP. Cardiovascular safety in depressed patients: Focus on venlafaxine. J Clin Psychiatry 1995;56:574-579.
22. Demyttenaere K, Jaspers L. Bupropion and SSRI-induced side effects. J Psychopharmacol. 2008;22:792-804.
23. Stahl SM, Zhang L, Damatarca C, Grady M. Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry 2003;64(Suppl 14):6-17.
24. Paganelli MO, Tanus-Santos JE, Sabha M, et al. Hemody-namic effects of bupropion in anesthetized dogs. Eur J Pharmacol. 2006;530:124-127.
25. Glassman AH, Bigger JT Jr. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-1782.
26. Erbguth PH, Reiman B, Klein RL. The influence of chlor-promazine, diazepam, and droperidol on emergence from ketamine. Anesth Analg. 1972;51:693-700.
27. Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 2000;23:215-228.
28. Meltzer HY, Davidson M, Glassman AH, Vieweg WV. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J Clin Psychiatry. 2002;63(Suppl 9):25-29.
29. Donnelly JG, MacLeod AD. Hypotension associated with clozapine after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1999;13:597-599.
30. Foster CA, Aston SJ. Propranolol-epinephrine interaction: A potential disaster. Plast Reconstr Surg. 1983;72:74-78.
31. Brantigan TA, Brantigan CO, Joseph NH. Beta-blockade and musical performance. Lancet 1978;2:896.
32. Black JW, Crowther RAF, Shanks RG, Smith LH, Dornhorst AC. A new adrenergic betareceptor antagonist. Lancet 1964; 1:1080-1081.
33. Houben H, Thien T, van't Laar A. Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Clin Pharmacol Ther. 1982;31:685-690.
34. Hendrix Y, van Zagten MS. Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan. Ned Tijdschr Geneeskd. 2005;149:888-890.
35. Jhee SS, Salazar DE, Ford NF, Fulmor IE, Sramek JJ, Cutler NR. A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension. Cephalalgia 1999;19:95-99.
36. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993;87:401-405.
37. Paterna S, Di Pasquale P, Antona A. Effects of sumatriptan on isolated rabbit heart. Drugs Exp Clin Res. 1995;21:37-40.
38. Abbrescia VD, Pearlstein L, Kotler M. Sumatriptan-associated myocardial infarction: Report of case with attention to potential risk factors. J Am Osteopath Assoc. 1997;97: 162-164.
39. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA. 1998;280:1569-1575.
40. LeakJA. Herbal medicine: Is it an alternative or an unknown? A brief review of popular herbals used by patients in a pain and symptom management practice setting. Curr Rev Pain 1999;3:226-236.
41. Heller J, GabbayJS, GhadjarK, etal. Top-10list of herbal and supplemental medicines used by cosmetic patients: What the plastic surgeon needs to know. Plast Reconstr Surg. 2006;117: 436-447.
42. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens. 1994;12:463-468.
43. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery 1990;26:880-882.
44. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286:208-216.
45. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997; 336:1108.
46. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775-1776.
47. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998;352:36.
48. Kimura Y, Okuda H, Arichi S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J Pharm Pharmacol. 1988;40:838-843.
49. Dega H, Laporte JL, Francès C, Herson S, Chosidow O. Ginseng as a cause for Stevens-Johnson syndrome? Lancet 1996;347:1344.
50. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol. 1988;159:1121-1122.
51. O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med. 1998;7:523-536.
52. Backon J. Ginger: Inhibition of thromboxane synthetase and stimulation of prostacyclin. Relevance for medicine and psychiatry. Med Hypotheses 1986;20:271-278.
53. Marles RJ, Kaminski J, Arnason JT, et al. A bioassay for inhibition of serotonin release from bovine platelets. J Nat Prod. 1992;55:1044-1056.
54. Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE. Anesthetic considerations of the herbal, kava. J Clin Anesth. 2004; 16:305-311.
55. Martin HB, Stofer WD, Eichinger MR. Kavain inhibits murine airway smooth muscle contraction. Planta Med. 2000; 66:601-606.
56. Czekalla J, Gastpar M, Hübner WD, Jäger D. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine. Pharmacopsychiatry 1997;30(Suppl 2):86-88.
57. Tinkelman DG, Avner SE. Ephedrine therapy in asthmatic children: Clinical tolerance and absence of side effects. JAMA. 1977;237:553-557.
58. Gurley BJ, Gardner SF, White LM, Wang PL. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit. 1998;20:439-445.
59. Ness J, Sherman FT, Pan CX. Alternative medicine: What the data say about common herbal therapies. Geriatrics 1999;54:33-38.
60. Miller LG. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998;158:2200-2211.
61. Cheng B, Hung CT, Chiu W. Herbal medicine and anaesthesia. Hong Kong Med J. 2002;8:123-130.
62. Whalley BJ. Herbal remedies-heilpflanzen. Phytother Res. 2000;1:656.
63. Cuddy ML. Commonly used herbs. J Pract Nurs. 2003;53:5-8.
64. An adverse reaction to the herbal medication milk thistle (Silybum marianum). Adverse Drug Reactions Advisory Committee. Med J Aust. 1999;170:218-219.
65. Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83:637-649.
66. Hall W. The respiratory risks of cannabis smoking. Addiction 1998;93:1461-1463.
67. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998;157:928-937.
68. Boyce SH, Quigley MA. Uvulitis and partial upper airway obstruction following cannabis inhalation. Emerg Med (Fremantle) 2002;14:106-108.
69. Cavero I, BuckleyJP, Jandhyala BS. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs. Eur J Pharmacol. 1973;24:243-251.
70. Gregg JM, Campbell RL, Levin KJ, GhiaJ, Elliott RA. Cardiovascular effects of cannabinol during oral surgery. Anesth Analg. 1976;55:203-213.
71. MaykutMO. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry 1985;9: 209-238.
72. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 1996;94:2337-2340.
73. Mayer K, Merfels M, Muhly-Reinholz M, et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: Role of endothelial PAF generation. Am J Physiol. 2002; 283:H811-H818.
74. Bruckner G, Webb P, Greenwell L, Chow C, Richardson D. Fish oil increases peripheral capillary blood cell velocity in humans. Atherosclerosis 1987;66:237-245.
75. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808.
76. Lu-Suguro JF, Hua J, Sakamoto K, Nagaoka I. Inhibitory action of glucosamine on platelet activation in guinea pigs. Inflamm Res. 2005;54:493-499.